Mutational profile of skin lesions in hepatocellular carcinoma patients under tyrosine kinase inhibition: a repercussion of a wide-spectrum activity

Background/Aim: Dermatological adverse events (DAE) in hepatocellular carcinoma (HCC) patients treated with sorafenib predicts better outcome. Some turn into skin lesions (SL) requiring pathology examination. We describe incidence, characteristics and molecular profile of SL in HCC patients treated...

Descripción completa

Detalles Bibliográficos
Autores principales: da Fonseca, Leonardo G., Fuster-Anglada, Carla, Carrera, Cristina, Millán, Cristina, Samper, Esther, Sapena, Victor, Díaz-González, Álvaro, Sanduzzi-Zamparelli, Marco, Leal, Cassia, Forner, Alejandro, Bruix, Jordi, Reig, Maria, Boix, Loreto, Díaz, Alba
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7939531/
https://www.ncbi.nlm.nih.gov/pubmed/33747359
http://dx.doi.org/10.18632/oncotarget.27891

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7939531/
https://www.ncbi.nlm.nih.gov/pubmed/33747359
http://dx.doi.org/10.18632/oncotarget.27891

Ejemplares similares